Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
In the UK, the importance of innovation in pathology is recognized in a recent NHS England report (Digital First: Clinical
transformation through pathology innovation). Digital Pathology (DP) is such an innovation with a potential to transform the
delivery of diagnostic histopathology services. At the end of 2015, the DP market was valued at US$327 Million, with a significant
increase in market value forecast. However, whilst there have been significant increases in market value along with advances in
DP, primary diagnostic use of this technology in the UK is not widespread. Internationally, there are several examples of digital
pathology (DP) utilization in Africa; North, South and Central America; Mexico; Asia (Japan, India) and Europe. The main drive
for implementation of DP in some countries is the unmet need of the population for quality diagnostic services and appropriately
trained staff. This talk will describe the diagnostic histopathology landscape in the UK and discuss strategies that may be adopted
to improve the uptake of this technology as a primary diagnostic tool. This will include our own work, in partnership with Philips
Digital Pathology Solutions to improve DP training and awareness. Examples of diagnostic DP implementation will be reviewed
in order to assess how such examples can inform strategies to improve adoption of DP in the UK.